GlassScriptPhysician profile
Tara Hanjan
NPI 1750326427
$2,143.61
in general payments reported to CMS, 2019-2025
11 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $387 · 2020: $381 · 2021: $730 · 2022: $215 · 2024: $285 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $430.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $969.40 | 2019-2024 | Lutonix Drug Coated Balloon |
| Cook Medical LLC | $207.61 | 2021-2024 | Tornado, Zenith Spiral-Z |
| Inari Medical, INC. | $194.10 | 2022 | |
| Stryker Corporation | $145.52 | 2025 | Artix Mt |
| Davol INC. | $143.15 | 2021 | |
| Boston Scientific Corporation | $124.07 | 2021 | |
| Karyopharm Therapeutics INC. | $118.31 | 2024 | Xpovio |
| Siemens Medical Solutions USA, INC. | $91.51 | 2019 | |
| Medtronic Vascular, INC. | $72.32 | 2019 | |
| Medtronic, INC. | $41.80 | 2024 | Concertotm |
| Becton, Dickinson and Company | $35.82 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tara Hanjan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.